These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3081245)

  • 1. The preclinical development of Roferon-A.
    Trown PW; Wills RJ; Kamm JJ
    Cancer; 1986 Apr; 57(8 Suppl):1648-56. PubMed ID: 3081245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients.
    Jones GJ; Itri LM
    Cancer; 1986 Apr; 57(8 Suppl):1709-15. PubMed ID: 3948143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical studies of recombinant interferon alfa-2a (Roferon-A) in cancer patients.
    Taguchi T
    Cancer; 1986 Apr; 57(8 Suppl):1705-8. PubMed ID: 3948142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma and the acquired immune deficiency syndrome. Treatment with recombinant interferon alpha and analysis of prognostic factors.
    Krown SE; Real FX; Vadhan-Raj S; Cunningham-Rundles S; Krim M; Wong G; Oettgen HF
    Cancer; 1986 Apr; 57(8 Suppl):1662-5. PubMed ID: 3081247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of recombinant interferon alfa-2a (Roferon-A) in metastatic melanoma using two different schedules .
    Legha SS; Papadopoulos NE; Plager C; Ring S; Chawla SP; Evans LM; Benjamin RS
    J Clin Oncol; 1987 Aug; 5(8):1240-6. PubMed ID: 3625246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation.
    Figlin RA; deKernion JB; Mukamel E; Palleroni AV; Itri LM; Sarna GP
    J Clin Oncol; 1988 Oct; 6(10):1604-10. PubMed ID: 3049952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of interferon alfa-2a, recombinant (Roferon-A) in metastatic renal cell carcinoma.
    Buzaid AC; Robertone A; Kisala C; Salmon SE
    J Clin Oncol; 1987 Jul; 5(7):1083-9. PubMed ID: 3598612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological effects of recombinant interferon alfa-2a in patients with disseminated melanoma.
    Hersey P; MacDonald M; Hall C; Spurling A; Edwards A; Coates A; McCarthy W
    Cancer; 1986 Apr; 57(8 Suppl):1666-74. PubMed ID: 3485011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic options in advanced cutaneous T cell lymphomas: a role for interferon alfa-2a (Roferon-A).
    Bunn PA; Foon KA
    Semin Oncol; 1985 Dec; 12(4 Suppl 5):18-24. PubMed ID: 3878594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of multiple myeloma with recombinant interferon alfa-2a.
    Ohno R; Kimura K
    Cancer; 1986 Apr; 57(8 Suppl):1685-8. PubMed ID: 3948139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant leukocyte interferon alfa-2a in the treatment of mycosis fungoides.
    Simoni R; Cavalieri R; Coppola G; Ricciotti L; De Pità O; Criscuolo D; Covelli A; Papa G; Mandelli F
    J Biol Regul Homeost Agents; 1987; 1(2):93-9. PubMed ID: 3504088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to recombinant interferon alfa-2a in hairy-cell leukemia associated with neutralizing anti-interferon antibodies.
    Steis RG; Smith JW; Urba WJ; Clark JW; Itri LM; Evans LM; Schoenberger C; Longo DL
    N Engl J Med; 1988 Jun; 318(22):1409-13. PubMed ID: 3367950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the in vitro host range of recombinant met-interferon-con1, interferon-alpha 2b, and interferon-beta [corrected].
    Hu CJ; Ozes ON; Klein SB; Blatt LM; Taylor MW
    J Interferon Cytokine Res; 1995 Mar; 15(3):231-4. PubMed ID: 7584668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of 5 patients affected by Kaposi's sarcoma and AIDS with recombinant interferon alfa-2A (roferon-A)].
    Lopez Bran E; Aguilar R; Marron JA; Figueredo MA; Garcia Ruiz JM
    Med Cutan Ibero Lat Am; 1989; 17(4):269-73. PubMed ID: 2693866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I-II trial of the combination of recombinant leukocyte A interferon and recombinant human interferon-gamma in patients with metastatic malignant melanoma.
    Creagan ET; Loprinzi CL; Ahmann DL; Schaid DJ
    Cancer; 1988 Dec; 62(12):2472-4. PubMed ID: 3142675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Roferon-A (interferon alfa-2a) permitted for AIDS-associated Kaposi's sarcoma by the BGA].
    Immun Infekt; 1989 Feb; 17(1):VIII. PubMed ID: 2925218
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon.
    Walter MR; Bordens R; Nagabhushan TL; Williams BR; Herberman RB; Dinarello CA; Borden EC; Trotta PP; Pestka S; Pfeffer LM
    Cancer Biother Radiopharm; 1998 Jun; 13(3):143-54. PubMed ID: 10850350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.
    Brook MG; McDonald JA; Karayiannis P; Caruso L; Forster G; Harris JR; Thomas HC
    Gut; 1989 Aug; 30(8):1116-22. PubMed ID: 2670693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Roferon-A. Canferon-A. Interferon alpha-2A (genetic recombination)].
    Taguchi T
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):171-6. PubMed ID: 3337525
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental (preclinical) study of genetically engineered human interferon based on recombinant clones of E. coli 74 and Pseudomonas Sp VG-84].
    Kalinin IuT; Vorob'ev AA; Parfenov VV; Titushkina TD; Fridman AIa
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Oct; (10):3-8. PubMed ID: 3911670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.